Compugen Financial Statements From 2010 to 2025
| CGEN Stock | ILA 711.20 3.20 0.45% |
Check Compugen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Compugen's main balance sheet or income statement drivers, such as , as well as many indicators such as . Compugen financial statements analysis is a perfect complement when working with Compugen Valuation or Volatility modules.
Compugen |
Compugen Company Shares Outstanding Analysis
Compugen's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Compugen Shares Outstanding | 86.62 M |
Most of Compugen's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Compugen is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Compugen has 86.62 M of shares currently outstending. This is 52.02% lower than that of the Healthcare sector and 18.93% lower than that of the Biotechnology industry. The shares outstanding for all Israel stocks is 84.85% higher than that of the company.
Compugen Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Compugen's current stock value. Our valuation model uses many indicators to compare Compugen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Compugen competition to find correlations between indicators driving Compugen's intrinsic value. More Info.Compugen is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Compugen by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Compugen's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Compugen Financial Statements
Compugen stakeholders use historical fundamental indicators, such as Compugen's revenue or net income, to determine how well the company is positioned to perform in the future. Although Compugen investors may analyze each financial statement separately, they are all interrelated. For example, changes in Compugen's assets and liabilities are reflected in the revenues and expenses on Compugen's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Compugen. Please read more on our technical analysis and fundamental analysis pages.
Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel, the United States, and Europe. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel. COMPUGEN operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 68 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Compugen Stock
When determining whether Compugen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Compugen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Compugen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Compugen Stock:Check out the analysis of Compugen Correlation against competitors. For information on how to trade Compugen Stock refer to our How to Trade Compugen Stock guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.